Literature DB >> 3372530

Regulation of human thymidine kinase during the cell cycle.

J L Sherley1, T J Kelly.   

Abstract

As an approach to defining the molecular basis for the periodic expression of thymidine kinase activity during the cell cycle, we have examined properties of the cytosolic enzyme in cycling HeLa cells synchronized by centrifugal elutriation and mitotic selection. By immunoblot analyses with a specific antiserum raised against the purified HeLa enzyme, we have demonstrated that changes in the levels of thymidine kinase activity reflect similar changes in the levels of thymidine kinase polypeptide. In contrast, the steady state levels of thymidine kinase mRNA show relatively small changes during the cell cycle. Using pulse labeling methods, we have shown that the synthetic rate of thymidine kinase protein is about 10-fold greater in S phase than in G1 phase, indicating that the efficiency of translation of thymidine kinase mRNA increases as cells begin DNA replication. In addition, the stability of thymidine kinase protein dramatically decreases upon cell division, resulting in the rapid clearance of the enzyme from newly divided G1 cells. Thus, two different post-transcriptional mechanisms largely account for the periodic behavior of the enzyme activity during the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3372530

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  114 in total

1.  A requirement for Zn2+ for the induction of thymidine kinase but not ornithine decarboxylase in 3T3 cells stimulated from quiescence.

Authors:  J K Chesters; L Petrie; A J Travis
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

2.  Molecular cloning and expression of the human deoxythymidylate kinase gene in yeast.

Authors:  J Y Su; R A Sclafani
Journal:  Nucleic Acids Res       Date:  1991-02-25       Impact factor: 16.971

3.  3'-(1,2,3-Triazol-1-yl)-3'-deoxythymidine analogs as substrates for human and Ureaplasma parvum thymidine kinase for structure-activity investigations.

Authors:  Jay Lin; Vincent Roy; Liya Wang; Li You; Luigi A Agrofoglio; Dominique Deville-Bonne; Tamara R McBrayer; Steven J Coats; Raymond F Schinazi; Staffan Eriksson
Journal:  Bioorg Med Chem       Date:  2010-03-15       Impact factor: 3.641

Review 4.  Development of radiotracers for oncology--the interface with pharmacology.

Authors:  Rohini Sharma; Eric Aboagye
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

5.  G1 cyclin degradation: the PEST motif of yeast Cln2 is necessary, but not sufficient, for rapid protein turnover.

Authors:  S R Salama; K B Hendricks; J Thorner
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

6.  Control of dTTP pool size by anaphase promoting complex/cyclosome is essential for the maintenance of genetic stability.

Authors:  Po-Yuan Ke; Yuan-Yeh Kuo; Chuan-Mei Hu; Zee-Fen Chang
Journal:  Genes Dev       Date:  2005-08-15       Impact factor: 11.361

7.  Expression of cyr61, a growth factor-inducible immediate-early gene.

Authors:  T P O'Brien; G P Yang; L Sanders; L F Lau
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

8.  Evaluation of 3'-deoxy-3'-[18F]-fluorothymidine (18F-FLT) kinetics correlated with thymidine kinase-1 expression and cell proliferation in newly diagnosed gliomas.

Authors:  Aya Shinomiya; Nobuyuki Kawai; Masaki Okada; Keisuke Miyake; Takehiro Nakamura; Yoshio Kushida; Reiji Haba; Nobuyuki Kudomi; Yuka Yamamoto; Masaaki Tokuda; Takashi Tamiya
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-11-15       Impact factor: 9.236

9.  The proliferation marker thymidine kinase 1 level is high in normal kidney tubule cells compared to other normal and malignant renal cells.

Authors:  Pengcheng Luo; Naining Wang; Ellen He; Staffan Eriksson; Ji Zhou; Guozhu Hu; Jie Zhang; Sven Skog
Journal:  Pathol Oncol Res       Date:  2009-12-03       Impact factor: 3.201

10.  Fetal dose estimates for (18)F-fluoro-L-thymidine using a pregnant monkey model.

Authors:  Rachel M Bartlett; Robert J Nickles; Todd E Barnhart; Bradley T Christian; James E Holden; Onofre T DeJesus
Journal:  J Nucl Med       Date:  2010-01-15       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.